Switzerland-based pharma solutions provider Linnea is targeting cosmetics and personal care thanks to new delivery technology that brings its botanical extracts to the skin care category for the first time.
Pierre Fabre is cutting 551 jobs in pharmaceutical research and development and sales by 2016, almost exclusively in France, as it focuses on expanding its cosmetics division abroad.
Allergan has long dominated the anti-wrinkle arena with its Botox product, but it appears cosmo-pharma giant Johnson & Johnson is preparing to offer serious competition, with the development of its latest drug.
Sales of dermocosmetics in Poland are tipped to increase, reaching one billion Polish zlotys (€245 million) in the next two years, as the country’s distribution channels become more diversified.
Ubertan, a tanning nasal spray that has failed to undergo any clinical tests is potentially dangerous, according to the Medicines and Healthcare products Regulatory Agency (MHRA).
Johnson & Johnson said sales for its US consumer products division were hard hit by a series of recalls during the period, but other divisions helped to boost the group result.
A US company's eyelash lengthening product is currently under
investigation by the Medicines and Healthcare products Regulatory
Agency (MHRA) in the UK following its removal from the US market.
Regulators seized about $2m worth of an eyelash lengthening
product, one of a new breed of beauty goods that fall into
regulatory no-man's land between drugs and cosmetics.
A new trend more commonly linked to the pharmaceutical industry is
emerging within cosmetics - with many consumers now using
transdermal drug delivery patches to help fight body issues such as
cellulite and eye contour wrinkles.
New Jersey-based IGI, a developer of technologies for skin care
applications, is making clear moves in preparation for a takeover,
after the company's financial representatives stated that some of
its past clients may be interested...
A US cosmetics company says it will try to further a technology it
has developed for skin care products in an attempt to break into
the drug delivery for cancer prevention treatments and gene repair
agents.
Preliminary studies find that a nanotech drug delivery system has
been developed to increase the efficacy of a prescription tanning
agent for fair-skinned people, reports Phil Taylor and Simon
Pitman.
Does the pharmaceutical industry's future lie at the boundary
between drugs and cosmetics? Or is the prospect of effective
'cosmeceuticals' a beauty myth? Writing in the 29 August issue of
'Nature' Helen Pearson...